Vimarsana
Biggest News Aggregation in the World

Page 17 - Cell Line News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Line Today - Breaking & Trending Today

Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030 - Vimarsana News

Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030

Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease - Vimarsana News

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

In this interview, we speak to Axol Bioscience about their human iPSC-derived cells and how they have the potential to revolutionize the field of neurodegenerative disease.

What is the role of adenoviruses in human health? - Vimarsana News

What is the role of adenoviruses in human health?

With advances in molecular biology informing recent developments in vaccinology, gene therapy, and other fields of medicine, human adenoviruses (HAdVs) have been of primary importance in medical research. A recent review looks at the promises of HAdVs, their potential dangers, and future challenges.

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease - Vimarsana News

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

In a recent study published in the journal Annals of Diagnostic Pathology, researchers in the United States evaluated the impact of coronavirus disease 2019 (COVID-19) on central nervous system (CNS) damage in Alzheimer's disease (AD).

ProteoNic Announces Broadening of GigaGen's Rights to 2G UNic™ Technology - Vimarsana News

ProteoNic Announces Broadening of GigaGen's Rights to 2G UNic™ Technology

LEIDEN, the Netherlands, November 1, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced the extension of its license agreement with GigaGen, a biotechnology company advancing transformative antibody drug...